Skip navigation

SME Forum

7th 09.15-19.30. 8th 09.00-13.00

EMBL-EBI, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD
Monday 7 to Tuesday 8 March 2016

To find out more about this event please click here


Monday, 7 March 2016

09.15 - Registration and refreshments

10.00 - Welcome from EMBL-EBI and One Nucleus
Dominic Clark, Industry Programme Manager, EMBL-EBI
Harriet Fear, Chief Executive, OneNucleus

10.30 - ELIXIR: the European infrastructure for life-science data – Latest news from ELIXIR
Andrew Smith, Senior External Relations Officer, ELIXIR

10.50 - The BioInnovation Centre at the Wellcome Trust Genome Campus
Adrian Ibrahim, Head of Business Development and Technology Transfer, Wellcome Trust Sanger Institute

11.00 - Large Molecular Drug Discovery Bioinformatics
John Prime, Oncology Research Data Scientist and Strategist, MedImmune

11.30 - EMBL-EBI data resources and services: what’s new
Mary Todd Bergman, Senior Communications Officer, EMBL-EBI

11.55 - Drug Discovery Resources: ChEMBL and more
Anne Hersey, Interim Team Leader, Chemogenomics, EMBL-EBI

12.25 - Lunch, networking and demonstrations by subject-matter experts
Andrew Cowley, Bioinformatics Trainer, EMBL-EBI
Abhik Mukhopadhyay and David Armstrong, PDBePISA, EMBL-EBI
Steven Jupe, Reactome
Margaret Duesbury, IntAct
Birgit Meldal, Complex Portal

13:20 - Introduction to EMBL-EBI Search and Train Online
Sarah Morgan, Training Programme, EMBL-EBI

13.30 - CTTV: a new platform for target-validation data
Jessica Vamathevan (GSK), Operations Director, Centre for Therapeutic Target Validation, CTTV

14.00 - The Sanger-AZ DREAM Challenge
Julio Saez-Rodriguez, Professor of Computational Biomedicine, RWTH-Aachen University Hospital, Aachen, Germany

14.30 - Breakout sessions (Dominic Clark to introduce)
Pre-competitive collaboration: Ian Harrow, representing the Pistoia Alliance, Inc.
Data Coordination: Guy Cochrane, Team Leader, European Nucleotide Archive, EMBL-EBI.
Global Alliance for Genomics and Health (GA4GH): Stephen Keenan, Global Alliance working Group Manager, EMBL-EBI.

15.00 - Break-out session

15.45 - Pause for refreshment

16.15 - Breakout session: feedback

17.00 - The GENE Consortium
Paul Jones
, CEO at Genomics Enterprises, Genomics England

17.30 - Panel discussion: future needs (Chair: Dominic Clark)
Mary Barlow, LFCF Programme Manager, EMBL-EBI
Jonathan Dry, Principal Scientist, AstraZeneca
Tony Jones, Director of Business Development, One Nucleus
Guy Cochrane, Team Leader, European Nucleotide Archive, EMBL-EBI.
Adrian Ibrahim, Head of Business Development and Technology Transfer, Wellcome Trust Sanger Institute

18.00-19.30    Networking reception in the EMBL-EBI South Building 

Tuesday, 8 March 2016

The second day of the Forum comprises a hands-on training course in Room V1-24, EMBL-EBI South Building. Topics include genomics resources and drug-discovery resources. Participation will be on a first-come, first-served basis, with a maximum number of 30 participants on the course.

09.00 - Welcome remarks (Dominic Clark)

09.15 - Train online
Sarah Morgan
, Training Programme manager, EMBL-EBI

09.30 - Ensembl: accessing the genome
Emily Perry
, Ensembl Outreach Officer, EMBL-EBI

11.00 - Break for refreshment

11.30 - The ChEMBL and SureChEMBL databases: Compound-Target Interactions from medicinal chemistry and patents
Anne Hersey
, Interim Team Leader, Chemogenomics, EMBL-EBI and George Papadatos, Senior Technical Officer, EMBL-EBI

13.00 - Lunch

14.00 - Departure
Title: SME Forum
Start: 2016-03-07 09:00:00Z
End: 2016-03-08 13:00:00Z